VITAZAL Trademark

Trademark Overview


On Tuesday, January 18, 2011, a trademark application was filed for VITAZAL with the United States Patent and Trademark Office. The USPTO has given the VITAZAL trademark a serial number of 85219806. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, January 25, 2011. This trademark is owned by Forest Laboratories, Inc.. The VITAZAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine
vitazal

General Information


Serial Number85219806
Word MarkVITAZAL
Filing DateTuesday, January 18, 2011
Status601 - ABANDONED - EXPRESS
Status DateTuesday, January 25, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of Hypertension, Isolated Systolic Hypertension, Essential Hypertension, Hypertension with Renal Disease, Primary Pulmonary Hypertension, Hypertension Encephalopathy, Congestive Heart Failure, Diastolic Heart Failure, Peripheral Vascular Disease, Left Ventricular Dysfunction following Myocardial Infarction, Definite or Suspected Acute Myocardial Infarction, Angina Pectoris, Chest Pain, Neuropathy in Type II Diabetics, Treatment of Endothelial Dysfunction, Coronary Artery Disease, Chronic Ischaemic Disease, Artrial Fibrillation and Flutter, Coronary Atherosclosis, Atheroscherosis Renal Arteries, Diabetes with Renal Manifestations, Mitral Valve Disorders, Aortic Valve Disorders, Tachycardia, Cardiac Dysrhythmias, Primary Cardiomyopathy, Metabolic Syndrome, Pulmonary Valve Disorder, Migraine, and Prevention of Migraine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 24, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameForest Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events


Event DateEvent Description
Tuesday, January 25, 2011ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Tuesday, January 25, 2011ABANDONMENT - EXPRESS MAILED
Monday, January 24, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Monday, January 24, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 21, 2011NEW APPLICATION ENTERED IN TRAM